Pilot study of tocilizumab monotherapy for active chronic periaortitis.

Anqi WangLinyi PengJiaxin ZhouZheng LiuHui LuYu PengJieqiong LiYunyun FeiWen Zhang

Published in: RMD open (2023)

Our study showed that TCZ monotherapy contributed to remarkable clinical and laboratory improvement in CP patients and could be an alternative treatment option for CP.

Keyphrases

combination therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
open label
rheumatoid arthritis
prognostic factors
clinical trial
peritoneal dialysis
smoking cessation